I’ve sat in enough boardrooms to know that NHI is either dominating the agenda – or being quietly avoided.
Both responses are wrong.
Here are the 3 questions every director of a healthcare-adjacent business should be asking right now:
- What is our OHSC compliance posture — honestly?
Not what management reports say. What a regulator walking in tomorrow would actually find. NHI accreditation will be the price of entry to the new system. Boards that don’t know their real compliance status are flying blind.
- What does our revenue model look like if medical scheme membership drops 20%?
Run the scenario. Model it. Have the uncomfortable conversation in the boardroom before the market forces it on you.
- Are we a buyer or a seller in the next 36 months?
Because distressed assets are already moving at prices that won’t last. The window for strategic acquisition – before international capital arrives and re-rates the sector – is open now. Not forever.
NHI is not an event. It’s a 15-year transition.
The boards that treat it like a crisis will react.
The boards that treat it like a market structure shift will position.
Which board are you on?